559 related articles for article (PubMed ID: 12364428)
21. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.
Raff H
J Clin Endocrinol Metab; 2009 Oct; 94(10):3647-55. PubMed ID: 19602555
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
[TBL] [Abstract][Full Text] [Related]
23. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the use of urinary cortisol to creatinine ratios and nocturnal salivary cortisol in the evaluation of cyclicity in patients with Cushing's syndrome.
Graham UM; Hunter SJ; McDonnell M; Mullan KR; Atkinson AB
J Clin Endocrinol Metab; 2013 Jan; 98(1):E72-6. PubMed ID: 23150688
[TBL] [Abstract][Full Text] [Related]
25. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
27. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.
Doi M; Sekizawa N; Tani Y; Tsuchiya K; Kouyama R; Tateno T; Izumiyama H; Yoshimoto T; Hirata Y
Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529
[TBL] [Abstract][Full Text] [Related]
28. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
29. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.
Putignano P; Toja P; Dubini A; Pecori Giraldi F; Corsello SM; Cavagnini F
J Clin Endocrinol Metab; 2003 Sep; 88(9):4153-7. PubMed ID: 12970280
[TBL] [Abstract][Full Text] [Related]
30. Pitfalls in the diagnosis and management of Cushing's syndrome.
Bansal V; El Asmar N; Selman WR; Arafah BM
Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
[TBL] [Abstract][Full Text] [Related]
31. Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?
Odeniyi IA; Fasanmade OA
Niger J Clin Pract; 2013; 16(3):269-72. PubMed ID: 23771444
[TBL] [Abstract][Full Text] [Related]
32. Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series.
Pecori Giraldi F; Ambrogio AG; De Martin M; Fatti LM; Scacchi M; Cavagnini F
J Clin Endocrinol Metab; 2007 Nov; 92(11):4123-9. PubMed ID: 17698908
[TBL] [Abstract][Full Text] [Related]
33. Salivary cortisol for screening of Cushing's syndrome in children.
Martinelli CE; Sader SL; Oliveira EB; Daneluzzi JC; Moreira AC
Clin Endocrinol (Oxf); 1999 Jul; 51(1):67-71. PubMed ID: 10468967
[TBL] [Abstract][Full Text] [Related]
34. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
35. Salivary cortisol as a tool for physiological studies and diagnostic strategies.
Castro M; Elias PC; Martinelli CE; Antonini SR; Santiago L; Moreira AC
Braz J Med Biol Res; 2000 Oct; 33(10):1171-5. PubMed ID: 11004717
[TBL] [Abstract][Full Text] [Related]
36. Specificity of screening tests for Cushing's syndrome in an overweight and obese population.
Baid SK; Rubino D; Sinaii N; Ramsey S; Frank A; Nieman LK
J Clin Endocrinol Metab; 2009 Oct; 94(10):3857-64. PubMed ID: 19602562
[TBL] [Abstract][Full Text] [Related]
37. Cushing's syndrome: update on signs, symptoms and biochemical screening.
Nieman LK
Eur J Endocrinol; 2015 Oct; 173(4):M33-8. PubMed ID: 26156970
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
Görges R; Knappe G; Gerl H; Ventz M; Stahl F
J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
[TBL] [Abstract][Full Text] [Related]
39. Cushing's Syndrome: Screening and Diagnosis.
Ceccato F; Boscaro M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
[TBL] [Abstract][Full Text] [Related]
40. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
